Search
for
Sort by
Research 31–60 of 1000+
- Tideglusib promotes wound healing in aged skin by activating PI3K/Akt pathway
- Role of FGFR2-signaling in the pathogenesis of acne
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- Comprehensive Review of Perilla frutescens: Chemical Composition, Pharmacological Mechanisms, and Industrial Applications in Food and Health Products
- Integrating stem cell biology and organoid technology for skin regenerative therapies
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Dermatologic Reactions to Targeted Therapy
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Cetuximab-Associated Elongation of the Eyelashes
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Cancer Treatments and Alopecia: A Systematic Review
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Green tea in dermatology - myths and facts
- Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- Controlled Release of the α-Tocopherol-Derived Metabolite α-13′-Carboxychromanol from Bacterial Nanocellulose Wound Cover Improves Wound Healing
- Potential Use of Spin Traps to Control ROS in Antipollution Cosmetics—A Review
- Abstracts
- Dermatologic Adverse Events from Cancer Treatments
- Acne and acneiform eruptions
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Adverse Hair Reactions to New Targeted Therapies for Cancer